Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

被引：0
|
作者：
Thitima Kongnakorn
Christian Eckmann
Matteo Bassetti
Eszter Tichy
Roberto Di Virgilio
Nathalie Baillon-Plot
Claudie Charbonneau
机构：
[1] Evidera,Klinikum Peine
[2] The Ark,Infectious Diseases Clinic, Department of Health Sciences
[3] Academic Hospital of Medical University Hannover,undefined
[4] University of Genoa,undefined
[5] Genoa and Hospital Policlinico San Martino IRCCS,undefined
[6] Evidera,undefined
[7] Pfizer,undefined
[8] Pfizer,undefined
来源：
Antimicrobial Resistance & Infection Control | / 8卷
关键词：
Economic model; Cost-effectiveness analysis; Ceftazidime-avibactam plus metronidazole; Ceftolozane/tazobactam plus metronidazole; Meropenem; Complicated intra-abdominal infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 41 条
  • [21] A randomized controlled trial comparing the efficacy of tigecycline versus meropenem in the treatment of postoperative complicated intra-abdominal infections
    Wang, Hai-Jun
    Xing, Xue-Zhong
    Qu, Shi-Ning
    Huang, Chu-Lin
    Zhang, Hao
    Wang, Hao
    Yang, Quan-Hui
    Yuan, Zhen-Nan
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (02) : 1262 - 1275
  • [22] A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia
    Qin, Xinyu
    Binh Giang Tran
    Kim, Min Ja
    Wang, Lie
    Dung Anh Nguyen
    Chen, Qian
    Song, Jie
    Laud, Peter J.
    Stone, Gregory G.
    Chow, Joseph W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (05) : 579 - 588
  • [23] TIGECYCLINE COST-EFFECTIVENESS ANALYSIS IN THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS: A PERSPECTIVE OF BRAZILIAN HEALTH SYSTEMS
    Ferreira, C. N.
    Squiassi, H. B.
    Santana, C. F.
    Figueiredo Valente, M. L.
    VALUE IN HEALTH, 2016, 19 (03) : A217 - A218
  • [24] Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection
    Jackson, Carl-Christian A.
    Newland, Jason
    Dementieva, Nataliia
    Lonchar, Julia
    Su, Feng-Hsiu
    Huntington, Jennifer A.
    Bensaci, Mekki
    Popejoy, Myra W.
    Johnson, Matthew G.
    De Anda, Carisa
    Rhee, Elizabeth G.
    Bruno, Christopher J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (07) : 557 - 563
  • [25] BUDGET IMPACT ANALYSIS OF CEFTOLOZANE/TAZOBACTAM (ZERBAXA) FORTHE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS AND COMPLICATED URINARY TRACT INFECTIONS IN THE ITALIAN SETTING
    Barbieri, M.
    Crocchiolo, D.
    Veneziano, M. A.
    VALUE IN HEALTH, 2016, 19 (07) : A409 - A409
  • [26] Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
    Prabhu, Vimalanand S.
    Solomkin, Joseph S.
    Medic, Goran
    Foo, Jason
    Borse, Rebekah H.
    Kauf, Teresa
    Miller, Benjamin
    Sen, Shuvayu S.
    Basu, Anirban
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2017, 6
  • [27] Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States
    Vimalanand S. Prabhu
    Joseph S. Solomkin
    Goran Medic
    Jason Foo
    Rebekah H. Borse
    Teresa Kauf
    Benjamin Miller
    Shuvayu S. Sen
    Anirban Basu
    Antimicrobial Resistance & Infection Control, 6
  • [28] COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME/AVIBACTAM FOR THE TREATMENT OF INTRABDOMINAL INFECTION DUE TO CARBAPENEM RESISTANT ENTEROBACTEREAS IN ARGENTINA
    Mac Mullen, M.
    Pein, C.
    VALUE IN HEALTH, 2020, 23 : S544 - S544
  • [29] The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials
    Cheng, I-Ling
    Chen, Yu-Hung
    Lai, Chih-Cheng
    Tang, Hung-Jen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
  • [30] BUDGET IMPACT ANALYSIS OF INTRODUCING CEFTOLOZANE/TAZOBACTAM INJECTION FOR TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS AND COMPLICATED URINARY TRACT INFECTIONS IN THE MINISTRY OF HEALTH MALAYSIA FACILITIES
    Idrus, N.
    VALUE IN HEALTH, 2022, 25 (01) : S57 - S57
12345